A National Cancer Institute Comprehensive Cancer Center

 
 

Health Encyclopedia

 

 

Replacement Therapy for Von Willebrand's Disease

Topic Overview

Replacement therapy is a treatment that replaces something that's missing or not working well in your body. People with von Willebrand's disease don't have von Willebrand factor, or it doesn't work well enough to help clot their blood. So shots (injections) of plasma and clotting factor VIII plus von Willebrand factor can be used as replacement therapy.

Replacement therapy injections (also called infusions) may be used with people who:

  • Do not respond to desmopressin.
  • Cannot tolerate desmopressin.
  • Have severe type 2 or type 3 von Willebrand's disease.
  • Have severe bleeding, from an injury or an unknown cause.

You may get this medicine in a hospital or take it at home. Patients often learn to inject themselves at home, but a doctor or nurse can give the shots too.

Plasma is usually taken from blood donations. In the United States, donated blood is carefully screened. Blood with any viruses, such as the human immunodeficiency virus (HIV) or viral hepatitis B, is not used. The chance of getting one of these viruses from plasma is extremely low. Plasma is screened and treated for viruses.

Replacement therapy doesn't always work well, because the body may stop the newly introduced von Willebrand factor from working.

Replacement therapy has changed over the years for von Willebrand's disease. Cryoprecipitate, which is a concentrated frozen plasma, is no longer used.

Related Information

References

Other Works Consulted

  • Kessler CM (2008). Hereditary von Willebrand's disease section of Hemorrhagic disorders: Coagulation factor deficiencies. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 23rd ed., pp. 1308–1311. Philadelphia: Saunders Elsevier.
  • National Heart, Lung, and Blood Institute (2007). The Diagnosis, Evaluation, and Management of von Willebrand Disease. (NIH Publication No. 08–5832). Available online: http://www.nhlbi.nih.gov/guidelines/vwd.

Credits

By Healthwise Staff
Primary Medical Reviewer E. Gregory Thompson, MD - Internal Medicine
Specialist Medical Reviewer Brian Leber, MDCM, FRCPC - Hematology
Last Revised November 22, 2010

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.